SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-042369
Filing Date
2010-08-05
Accepted
2010-08-05 16:05:43
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-11924_110q.htm 10-Q 1128591
2 EX-10.1 a10-11924_1ex10d1.htm EX-10.1 21622
3 EX-31.1 a10-11924_1ex31d1.htm EX-31.1 12134
4 EX-31.2 a10-11924_1ex31d2.htm EX-31.2 12107
5 EX-32.1 a10-11924_1ex32d1.htm EX-32.1 6122
  Complete submission text file 0001104659-10-042369.txt   4473625

Data Files

Seq Description Document Type Size
6 EX-101.INS amln-20100630.xml EX-101.INS 678786
7 EX-101.SCH amln-20100630.xsd EX-101.SCH 20823
8 EX-101.CAL amln-20100630_cal.xml EX-101.CAL 39096
9 EX-101.LAB amln-20100630_lab.xml EX-101.LAB 212461
10 EX-101.PRE amln-20100630_pre.xml EX-101.PRE 108164
11 EX-101.DEF amln-20100630_def.xml EX-101.DEF 68618
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 10994509
SIC: 2834 Pharmaceutical Preparations